COMPAGNIE ODET 1 028.000 € (+2,59 %)
AXA 42.150 € (+0,19 %)
KERING 209.250 € (-0,50 %)
LAGARDERE SA 18.000 € (0,00 %)
PEUGEOT INVEST 51.600 € (0,00 %)
BE SEMICONDUCTOR 203.000 € (-0,88 %)
LVMH 380.900 € (+0,62 %)
ARTMARKET COM 3.270 € (-2,10 %)
AHOLD DEL 31.460 € (-0,13 %)
AIR LIQUIDE 170.760 € (+0,35 %)
BNP PARIBAS ACT.A 92.760 € (+0,76 %)
SAINT GOBAIN 66.120 € (-1,46 %)
DSM FIRMENICH AG 97.200 € (+1,08 %)
AKZO NOBEL 57.720 € (+1,83 %)
CBO TERRITORIA 3.580 € (-3,50 %)
L'OREAL 373.450 € (+0,19 %)
HEIJMANS KON 85.500 € (-3,88 %)
ING GROEP N.V. 31.035 € (+1,14 %)
BANIJAY GROUP 8.200 € (0,00 %)
HAFFNER ENERGY 0.784 € (+7,69 %)
ASML HOLDING 1 656.200 € (+0,19 %)
ARCADIS 40.100 € (+1,31 %)
TIKEHAU CAPITAL 15.640 € (-0,26 %)
GECINA 60.200 € (+1,35 %)
FORVIA 8.734 € (+1,63 %)
PROSUS 35.285 € (+2,28 %)
STIF 19.500 € (+2,69 %)
GROUPE CRIT 48.300 € (+0,21 %)
FERMENTALG 0.467 € (+2,75 %)
ARCELORMITTAL SA 57.600 € (+0,56 %)
IMCD 95.720 € (+0,53 %)
ELIS 21.420 € (+0,56 %)
VINCI 106.150 € (-0,61 %)
GTT 213.000 € (+1,43 %)
AIRBUS 189.080 € (-0,12 %)
SANOFI 69.990 € (-1,16 %)
ESSILORLUXOTTICA 144.500 € (+1,19 %)
UNILEVER 53.080 € (+0,45 %)
AUBAY 49.650 € (-0,70 %)
ACCOR 43.700 € (-1,13 %)
ABN AMRO BANK N.V. 42.350 € (+0,95 %)
HERMES INTL 1 286.000 € (-1,04 %)
INTERPARFUMS 30.100 € (+1,28 %)
VALLOUREC 18.395 € (+2,97 %)
CROSSJECT 1.310 € (0,00 %)
VEOLIA ENVIRON. 30.460 € (-0,88 %)
CREDIT AGRICOLE 16.930 € (+0,27 %)
STMICROELECTRONICS 50.870 € (+1,05 %)
EURAZEO 44.680 € (-0,27 %)
VIEL ET COMPAGNIE 18.300 € (+0,33 %)
TOTALENERGIES 75.800 € (+1,80 %)
SAFRAN 329.800 € (-0,09 %)
MR BRICOLAGE 2.840 € (-4,05 %)
BUREAU VERITAS 26.330 € (-0,90 %)
NETGEM 1.015 € (-1,93 %)
LINEDATA SERVICES 54.000 € (-0,37 %)
FOUNTAINE PAJOT 75.700 € (-3,57 %)
MGI DIGITAL GRAPHI 8.320 € (-2,46 %)
EBUSCO HOLDING 0.194 € (-0,31 %)
EDENRED 27.250 € (+0,55 %) |
14/09/2026 08:05
Intuitive announces expanded indication for da Vinci SP in EuropeEQS-News: Intuitive / Key word(s): Miscellaneous/Miscellaneous CE mark for transvaginal gynecologic procedures expands SP's applications AUBONNE, Switzerland, Sept. 14, 2026 /PRNewswire/ -- Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced CE mark approval for the indication of transvaginal gynecologic procedures for the da Vinci SP (Single Port) surgical system – marking a world's-first indication for the SP system.
This approval expands da Vinci SP's CE-marked applications in Europe, which currently include endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast surgical procedures. "Building on the strong adoption of da Vinci SP in women's health, this approval is a meaningful step forward, not just as a regulatory milestone, but because it expands access to less invasive options for women across Europe and opens the door to potentially better recovery experiences and outcomes," said Dirk Barten, Intuitive commercial president for Europe. The da Vinci SP system enables surgeons to perform procedures through a single incision or natural orifice, offering enhanced visualization and precision in narrow or deep anatomical spaces. Through a single-entry point, surgeons can control up to three multi-jointed instruments and a fully articulating 3DHD endoscope, enabling access to complex anatomy with minimal disruption to surrounding tissue. "Transvaginal procedures expand the natural orifice surgery portfolio of the da Vinci SP System, which to this day includes successful transoral and transanal procedures," said Tilman Schlick, vice president, medical affairs & medical officer at Intuitive in Europe. "These less invasive, scarless surgery approaches have the potential to shorten recovery times and enhance patients' experience as they return to their daily lives. As we continue to innovate across our platforms, we remain focused on helping more patients access the benefits of minimally invasive care." A growing body of evidence, including more than 1,000 peer-reviewed publications, supports the safety, efficacy, and patient outcomes associated with the da Vinci SP system. Da Vinci SP is also approved for use in the US, Japan, and Korea for a range of procedures spanning multiple surgical disciplines. Images About Intuitive About da Vinci Surgical Systems For more information, please visit the company's website at www.intuitive.com/en-gb This material may contain estimates and forecasts from which actual results may differ. Some products, features or technologies may not be available in all countries. Please contact your local Intuitive representative for product availability in your region. Refer to the product specific User Manual for indications, contraindications, warnings and other product information. © 2026 Intuitive Surgical Operations, Inc. All rights reserved. Product and brand names/logos, including Intuitive, da Vinci, and Ion, are trademarks or registered trademarks of Intuitive Surgical or their respective owner. See intuitive.com/trademarks.
![]() 14.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. 2398358 14.09.2026 CET/CEST Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière

